Copyright Reports & Markets. All rights reserved.

Global Diagnostic Nuclear Drug Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered: Ranking by Diagnostic Nuclear Drug Revenue
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Diagnostic Nuclear Drug Market Size Growth Rate by Type: 2020 VS 2026
      • 1.4.2 Tc-99m
      • 1.4.3 F-18
      • 1.4.4 Other
    • 1.5 Market by Application
      • 1.5.1 Global Diagnostic Nuclear Drug Market Share by Application: 2020 VS 2026
      • 1.5.2 Oncology
      • 1.5.3 Cardiology
      • 1.5.4 Other
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends by Regions

    • 2.1 Diagnostic Nuclear Drug Market Perspective (2015-2026)
    • 2.2 Diagnostic Nuclear Drug Growth Trends by Regions
      • 2.2.1 Diagnostic Nuclear Drug Market Size by Regions: 2015 VS 2020 VS 2026
      • 2.2.2 Diagnostic Nuclear Drug Historic Market Share by Regions (2015-2020)
      • 2.2.3 Diagnostic Nuclear Drug Forecasted Market Size by Regions (2021-2026)
    • 2.3 Industry Trends and Growth Strategy
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Challenges
      • 2.3.4 Porter’s Five Forces Analysis
      • 2.3.5 Diagnostic Nuclear Drug Market Growth Strategy
      • 2.3.6 Primary Interviews with Key Diagnostic Nuclear Drug Players (Opinion Leaders)

    3 Competition Landscape by Key Players

    • 3.1 Global Top Diagnostic Nuclear Drug Players by Market Size
      • 3.1.1 Global Top Diagnostic Nuclear Drug Players by Revenue (2015-2020)
      • 3.1.2 Global Diagnostic Nuclear Drug Revenue Market Share by Players (2015-2020)
      • 3.1.3 Global Diagnostic Nuclear Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    • 3.2 Global Diagnostic Nuclear Drug Market Concentration Ratio
      • 3.2.1 Global Diagnostic Nuclear Drug Market Concentration Ratio (CR5 and HHI)
      • 3.2.2 Global Top 10 and Top 5 Companies by Diagnostic Nuclear Drug Revenue in 2019
    • 3.3 Diagnostic Nuclear Drug Key Players Head office and Area Served
    • 3.4 Key Players Diagnostic Nuclear Drug Product Solution and Service
    • 3.5 Date of Enter into Diagnostic Nuclear Drug Market
    • 3.6 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type (2015-2026)

    • 4.1 Global Diagnostic Nuclear Drug Historic Market Size by Type (2015-2020)
    • 4.2 Global Diagnostic Nuclear Drug Forecasted Market Size by Type (2021-2026)

    5 Diagnostic Nuclear Drug Breakdown Data by Application (2015-2026)

    • 5.1 Global Diagnostic Nuclear Drug Market Size by Application (2015-2020)
    • 5.2 Global Diagnostic Nuclear Drug Forecasted Market Size by Application (2021-2026)

    6 North America

    • 6.1 North America Diagnostic Nuclear Drug Market Size (2015-2020)
    • 6.2 Diagnostic Nuclear Drug Key Players in North America (2019-2020)
    • 6.3 North America Diagnostic Nuclear Drug Market Size by Type (2015-2020)
    • 6.4 North America Diagnostic Nuclear Drug Market Size by Application (2015-2020)

    7 Europe

    • 7.1 Europe Diagnostic Nuclear Drug Market Size (2015-2020)
    • 7.2 Diagnostic Nuclear Drug Key Players in Europe (2019-2020)
    • 7.3 Europe Diagnostic Nuclear Drug Market Size by Type (2015-2020)
    • 7.4 Europe Diagnostic Nuclear Drug Market Size by Application (2015-2020)

    8 China

    • 8.1 China Diagnostic Nuclear Drug Market Size (2015-2020)
    • 8.2 Diagnostic Nuclear Drug Key Players in China (2019-2020)
    • 8.3 China Diagnostic Nuclear Drug Market Size by Type (2015-2020)
    • 8.4 China Diagnostic Nuclear Drug Market Size by Application (2015-2020)

    9 Japan

    • 9.1 Japan Diagnostic Nuclear Drug Market Size (2015-2020)
    • 9.2 Diagnostic Nuclear Drug Key Players in Japan (2019-2020)
    • 9.3 Japan Diagnostic Nuclear Drug Market Size by Type (2015-2020)
    • 9.4 Japan Diagnostic Nuclear Drug Market Size by Application (2015-2020)

    10 Southeast Asia

    • 10.1 Southeast Asia Diagnostic Nuclear Drug Market Size (2015-2020)
    • 10.2 Diagnostic Nuclear Drug Key Players in Southeast Asia (2019-2020)
    • 10.3 Southeast Asia Diagnostic Nuclear Drug Market Size by Type (2015-2020)
    • 10.4 Southeast Asia Diagnostic Nuclear Drug Market Size by Application (2015-2020)

    11 India

    • 11.1 India Diagnostic Nuclear Drug Market Size (2015-2020)
    • 11.2 Diagnostic Nuclear Drug Key Players in India (2019-2020)
    • 11.3 India Diagnostic Nuclear Drug Market Size by Type (2015-2020)
    • 11.4 India Diagnostic Nuclear Drug Market Size by Application (2015-2020)

    12 Central & South America

    • 12.1 Central & South America Diagnostic Nuclear Drug Market Size (2015-2020)
    • 12.2 Diagnostic Nuclear Drug Key Players in Central & South America (2019-2020)
    • 12.3 Central & South America Diagnostic Nuclear Drug Market Size by Type (2015-2020)
    • 12.4 Central & South America Diagnostic Nuclear Drug Market Size by Application (2015-2020)

    13 Key Players Profiles

    • 13.1 Bracco Imaging
      • 13.1.1 Bracco Imaging Company Details
      • 13.1.2 Bracco Imaging Business Overview and Its Total Revenue
      • 13.1.3 Bracco Imaging Diagnostic Nuclear Drug Introduction
      • 13.1.4 Bracco Imaging Revenue in Diagnostic Nuclear Drug Business (2015-2020))
      • 13.1.5 Bracco Imaging Recent Development
    • 13.2 Bayer
      • 13.2.1 Bayer Company Details
      • 13.2.2 Bayer Business Overview and Its Total Revenue
      • 13.2.3 Bayer Diagnostic Nuclear Drug Introduction
      • 13.2.4 Bayer Revenue in Diagnostic Nuclear Drug Business (2015-2020)
      • 13.2.5 Bayer Recent Development
    • 13.3 Curium Pharmaceuticals
      • 13.3.1 Curium Pharmaceuticals Company Details
      • 13.3.2 Curium Pharmaceuticals Business Overview and Its Total Revenue
      • 13.3.3 Curium Pharmaceuticals Diagnostic Nuclear Drug Introduction
      • 13.3.4 Curium Pharmaceuticals Revenue in Diagnostic Nuclear Drug Business (2015-2020)
      • 13.3.5 Curium Pharmaceuticals Recent Development
    • 13.4 Nordion
      • 13.4.1 Nordion Company Details
      • 13.4.2 Nordion Business Overview and Its Total Revenue
      • 13.4.3 Nordion Diagnostic Nuclear Drug Introduction
      • 13.4.4 Nordion Revenue in Diagnostic Nuclear Drug Business (2015-2020)
      • 13.4.5 Nordion Recent Development
    • 13.5 Triad Isotopes
      • 13.5.1 Triad Isotopes Company Details
      • 13.5.2 Triad Isotopes Business Overview and Its Total Revenue
      • 13.5.3 Triad Isotopes Diagnostic Nuclear Drug Introduction
      • 13.5.4 Triad Isotopes Revenue in Diagnostic Nuclear Drug Business (2015-2020)
      • 13.5.5 Triad Isotopes Recent Development
    • 13.6 Lantheus
      • 13.6.1 Lantheus Company Details
      • 13.6.2 Lantheus Business Overview and Its Total Revenue
      • 13.6.3 Lantheus Diagnostic Nuclear Drug Introduction
      • 13.6.4 Lantheus Revenue in Diagnostic Nuclear Drug Business (2015-2020)
      • 13.6.5 Lantheus Recent Development
    • 13.7 GE Healthcare
      • 13.7.1 GE Healthcare Company Details
      • 13.7.2 GE Healthcare Business Overview and Its Total Revenue
      • 13.7.3 GE Healthcare Diagnostic Nuclear Drug Introduction
      • 13.7.4 GE Healthcare Revenue in Diagnostic Nuclear Drug Business (2015-2020)
      • 13.7.5 GE Healthcare Recent Development
    • 13.8 China Isotope & Radiation
      • 13.8.1 China Isotope & Radiation Company Details
      • 13.8.2 China Isotope & Radiation Business Overview and Its Total Revenue
      • 13.8.3 China Isotope & Radiation Diagnostic Nuclear Drug Introduction
      • 13.8.4 China Isotope & Radiation Revenue in Diagnostic Nuclear Drug Business (2015-2020)
      • 13.8.5 China Isotope & Radiation Recent Development
    • 13.9 Jubilant Pharma
      • 13.9.1 Jubilant Pharma Company Details
      • 13.9.2 Jubilant Pharma Business Overview and Its Total Revenue
      • 13.9.3 Jubilant Pharma Diagnostic Nuclear Drug Introduction
      • 13.9.4 Jubilant Pharma Revenue in Diagnostic Nuclear Drug Business (2015-2020)
      • 13.9.5 Jubilant Pharma Recent Development
    • 13.10 Eli Lilly
      • 13.10.1 Eli Lilly Company Details
      • 13.10.2 Eli Lilly Business Overview and Its Total Revenue
      • 13.10.3 Eli Lilly Diagnostic Nuclear Drug Introduction
      • 13.10.4 Eli Lilly Revenue in Diagnostic Nuclear Drug Business (2015-2020)
      • 13.10.5 Eli Lilly Recent Development
    • 13.11 Novartis
      • 10.11.1 Novartis Company Details
      • 10.11.2 Novartis Business Overview and Its Total Revenue
      • 10.11.3 Novartis Diagnostic Nuclear Drug Introduction
      • 10.11.4 Novartis Revenue in Diagnostic Nuclear Drug Business (2015-2020)
      • 10.11.5 Novartis Recent Development
    • 13.12 SIEMENS
      • 10.12.1 SIEMENS Company Details
      • 10.12.2 SIEMENS Business Overview and Its Total Revenue
      • 10.12.3 SIEMENS Diagnostic Nuclear Drug Introduction
      • 10.12.4 SIEMENS Revenue in Diagnostic Nuclear Drug Business (2015-2020)
      • 10.12.5 SIEMENS Recent Development
    • 13.13 Dongcheng
      • 10.13.1 Dongcheng Company Details
      • 10.13.2 Dongcheng Business Overview and Its Total Revenue
      • 10.13.3 Dongcheng Diagnostic Nuclear Drug Introduction
      • 10.13.4 Dongcheng Revenue in Diagnostic Nuclear Drug Business (2015-2020)
      • 10.13.5 Dongcheng Recent Development
    • 13.14 Navidea
      • 10.14.1 Navidea Company Details
      • 10.14.2 Navidea Business Overview and Its Total Revenue
      • 10.14.3 Navidea Diagnostic Nuclear Drug Introduction
      • 10.14.4 Navidea Revenue in Diagnostic Nuclear Drug Business (2015-2020)
      • 10.14.5 Navidea Recent Development

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
        • 15.1.2 Data Source
      • 15.2 Disclaimer

      This report focuses on the global Diagnostic Nuclear Drug status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Diagnostic Nuclear Drug development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

      The key players covered in this study
      Bracco Imaging
      Bayer
      Curium Pharmaceuticals
      Nordion
      Triad Isotopes
      Lantheus
      GE Healthcare
      China Isotope & Radiation
      Jubilant Pharma
      Eli Lilly
      Novartis
      SIEMENS
      Dongcheng
      Navidea

      Market segment by Type, the product can be split into
      Tc-99m
      F-18
      Other
      Market segment by Application, split into
      Oncology
      Cardiology
      Other

      Market segment by Regions/Countries, this report covers
      North America
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Diagnostic Nuclear Drug status, future forecast, growth opportunity, key market and key players.
      To present the Diagnostic Nuclear Drug development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by type, market and key regions.

      In this study, the years considered to estimate the market size of Diagnostic Nuclear Drug are as follows:
      History Year: 2015-2019
      Base Year: 2019
      Estimated Year: 2020
      Forecast Year 2020 to 2026
      For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now